D.E. Shaw
http://www.deshaw.com/
The D. E. Shaw is one of the world's largest hedge funds.
The D. E. Shaw has more than 1,300 employees; approximately $35 billion in aggregate investment capital as of November 1, 2007; and offices in North America, Europe, and Asia.
DE Shaw is know for its quantitative strategies - those using mathematical techniques to identify profit opportunities - but also uses qualitative strategies- based on the identification of profit opportunities by human experts.
The D.E. Shaw Group Sas founded by David E. Shaw in 1988. He continues to serve as chairman and CEO.
View Older Stories
-
Form SCHEDULE 13G/A WABASH NATIONAL Corp Filed by: D. E. SHAW & CO, L.P.
-
Form SCHEDULE 13G/A Opendoor Technologies Filed by: D. E. SHAW & CO, L.P.
-
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: D. E. SHAW & CO, L.P.
-
Form SCHEDULE 13G/A Keros Therapeutics, Inc. Filed by: D. E. SHAW & CO, L.P.
-
Form SCHEDULE 13G/A Xponential Fitness, Inc. Filed by: D. E. SHAW & CO, L.P.
-
Form SCHEDULE 13G/A Bloom Energy Corp Filed by: D. E. SHAW & CO, L.P.
-
Form 13F-NT D. E. Shaw Composite For: Dec 31
-
Form 13F-NT D. E. Shaw Multi-Asset For: Dec 31
-
Form 13F-NT D. E. Shaw Adviser II, For: Dec 31
-
Form 13F-NT D. E. Shaw Heliant Advis For: Dec 31
-
Form 13F-NT D. E. Shaw Investment For: Dec 31
-
Form 13F-NT D. E. SHAW & CO, L.P. For: Dec 31
-
Form 13F-HR D. E. Shaw & Co., Inc. For: Dec 31
-
Anthropic valued at $380 billion in latest $30 billion funding round
-
Anthropic raises $30 billion in series G funding at $380 billion post-money valuation
-
CoStar Group responds to D.E. Shaw's board control push
-
D.E. Shaw criticizes CoStar management, plans shareholder action
-
D.E. Shaw to Push for Board Shake-Up, Other Changes at Real-Estate Data Giant CoStar - WSJ
-
CoStar Group announces $1.5 billion share repurchase program
-
Third Point launches proxy battle against CoStar Group board
-
Third Point Sends Letter to Board of Directors of CoStar Group
-
Loeb's Third Point plans to take aim at CoStar in new activist campaign
-
Form SCHEDULE 13G/A Cable One, Inc. Filed by: D. E. SHAW & CO, L.P.
-
Comcast's Universal Ads names David Shaw head of global expansion
-
Comcast’s Universal Ads Appoints David Shaw as Head of Global Expansion to Oversee Platform's International Rollout
-
Mytra Raises $120M Series C to Scale Operating System for Supply Chain
-
Form SCHEDULE 13G/A CENTRUS ENERGY CORP Filed by: D. E. SHAW & CO, L.P.
-
Strong year for hedge funds drives big gains for Wall Street's prime brokerage engine
-
Threadlock Precision, Supported by The D. E. Shaw Group, Acquires Kremin Inc. to Expand U.S. Aerospace and Defense Precision Manufacturing Network
-
Neural Concept Introduces a Physics- and Geometry-Aware AI Design Copilot, Extending Its Established Engineering AI Platform
-
Factbox-Top hedge funds led by D.E.Shaw, Bridgewater and Balyasny deliver big gains in 2025
-
Form D D. E. Shaw Orienteer
-
ETHZilla appoints two independent directors to board
-
ETHZilla appoints two independent directors to board
-
ETHZilla Announces Appointment of Angela Dalton and Michael Edwards to Board of Directors
-
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering
-
Form SCHEDULE 13G Cable One, Inc. Filed by: D. E. SHAW & CO, L.P.
-
Arcesium Unveils New Suite of AI Features in Aquata® to Help Institutional Investors Scale Their AI Strategies
-
The OpenFold Consortium Names Dr. Jan Domanski as Senior Science Lead to Drive the Next Generation of Open Source AI Models for Structural Biology and Drug Discovery
-
FactSet and Arcesium partner to unify asset management workflows
-
FactSet and Arcesium Debut Tech To Unite Front, Middle, and Back Office Workflows for Asset Owners and Managers
-
Form SCHEDULE 13D ENVIRI Corp Filed by: D. E. SHAW & CO, L.P.
-
Form SCHEDULE 13G Opendoor Technologies Filed by: D. E. SHAW & CO, L.P.
-
Form 13F-NT D. E. Shaw Adviser, L.L. For: Sep 30
-
Form 13F-NT D. E. Shaw Adviser II, For: Sep 30
-
Form 13F-NT D. E. Shaw Heliant Advis For: Sep 30
-
Form 13F-NT D. E. Shaw Investment For: Sep 30
-
Form SCHEDULE 13G ARVINAS, INC. Filed by: D. E. SHAW & CO, L.P.
-
Form SCHEDULE 13G/A Sarepta Therapeutics, Filed by: D. E. SHAW & CO, L.P.
-
Form 13F-NT D. E. SHAW & CO, L.P. For: Sep 30

